Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 25, Number 3—March 2019

Synopsis

University-Based Outbreaks of Meningococcal Disease Caused by Serogroup B, United States, 2013–2018

Heidi M. SoetersComments to Author , Lucy A. McNamara, Amy E. Blain, Melissa Whaley, Jessica R. MacNeil, Susan Hariri, Sarah A. Mbaeyi, and for the Serogroup B Meningococcal Disease University Outbreak Group
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Figure 1

Timing of case onset dates and initiation of vaccination efforts during university-based outbreaks of meningococcal disease caused by serogroup B, United States, 2013–2018. MenB, serogroup B meningococcal vaccine.

Figure 1. Timing of case onset dates and initiation of vaccination efforts during university-based outbreaks of meningococcal disease caused by serogroup B, United States, 2013–2018. MenB, serogroup B meningococcal vaccine.

Main Article

1Members of the group are listed at the end of this article.

Page created: February 19, 2019
Page updated: February 19, 2019
Page reviewed: February 19, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external